Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Exchange Rate Effect (2023 - 2025)

Historic Exchange Rate Effect for Mereo BioPharma (MREO) over the last 3 years, with Q3 2025 value amounting to -$418000.0.

  • Mereo BioPharma's Exchange Rate Effect fell 13471.76% to -$418000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $657000.0, marking a year-over-year decrease of 7574.75%. This contributed to the annual value of -$233000.0 for FY2024, which is 10826.83% down from last year.
  • As of Q3 2025, Mereo BioPharma's Exchange Rate Effect stood at -$418000.0, which was down 13471.76% from $1.4 million recorded in Q2 2025.
  • Mereo BioPharma's Exchange Rate Effect's 5-year high stood at $1.7 million during Q4 2023, with a 5-year trough of -$1.3 million in Q4 2024.
  • In the last 3 years, Mereo BioPharma's Exchange Rate Effect had a median value of $846000.0 in 2023 and averaged $409272.7.
  • In the last 5 years, Mereo BioPharma's Exchange Rate Effect crashed by 17491.08% in 2024 and then soared by 143364.49% in 2025.
  • Over the past 3 years, Mereo BioPharma's Exchange Rate Effect (Quarter) stood at $1.7 million in 2023, then tumbled by 174.91% to -$1.3 million in 2024, then soared by 66.83% to -$418000.0 in 2025.
  • Its Exchange Rate Effect stands at -$418000.0 for Q3 2025, versus $1.4 million for Q2 2025 and $908000.0 for Q1 2025.